Ya-Fang Chang

机构：GlaxoSmithKline (United States)

发表论文 83 篇 · 总被引 2976 次 · h-index 23

代表论文

• Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis (2021 · Cell · 被引 384)
• EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer (2021 · Theranostics · 被引 86)
• Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer (2021 · Breast Cancer Research · 被引 84)
• Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma (2022 · Nature Communications · 被引 57)
• Facilitating Drug Discovery in Breast Cancer by Virtually Screening Patients Using In Vitro Drug Response Modeling (2021 · Cancers · 被引 15)
• Lasofoxifene as a potential treatment for ER+ metastatic breast cancer. (2019 · Journal of Clinical Oncology · 被引 7)